Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Immunogenik, Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Immunogenik, Inc.

Private

Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: XGX9CKVE5N68

Founded: —Source: [GOV]
Headquarters: GAINESVILLE, FloridaSource: [GOV]
Headcount: 3Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Immunogenik, Inc. has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $797,994 in 2025. These are non-dilutive federal research grants, not equity financing. The company is based in GAINESVILLE, Florida.

Funding rounds

2 rounds

STTR Phase I award (HHS)GrantJun 2025Source: [GOV]
$399K
—post-money
STTR Phase I award (HHS)

Investors

No investors recorded yet for Immunogenik, Inc..

Add an investor

People

Leadership

JIANPING HUANGPrincipal investigatorSince 2025Source: [GOV]

Acquisitions

Immunogenik, Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Immunogenik, Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Grant

Jul 2025Source: [GOV]

$399K

—post-money